Literature DB >> 23788430

Non-invasive neural stem cells become invasive in vitro by combined FGF2 and BMP4 signaling.

Martin H M Sailer1, Alexandra Gerber, Cristóbal Tostado, Gregor Hutter, Dominik Cordier, Luigi Mariani, Marie-Françoise Ritz.   

Abstract

Neural stem cells (NSCs) typically show efficient self-renewal and selective differentiation. Their invasion potential, however, is not well studied. In this study, Sox2-positive NSCs from the E14.5 rat cortex were found to be non-invasive and showed only limited migration in vitro. By contrast, FGF2-expanded NSCs showed a strong migratory and invasive phenotype in response to the combination of FGF2 and BMP4. Invasive NSCs expressed Podoplanin (PDPN) and p75NGFR (Ngfr) at the plasma membrane after exposure to FGF2 and BMP4. FGF2 and BMP4 together upregulated the expression of Msx1, Snail1, Snail2, Ngfr, which are all found in neural crest (NC) cells during or after epithelial-mesenchymal transition (EMT), but not in forebrain stem cells. Invasive cells downregulated the expression of Olig2, Sox10, Egfr, Pdgfra, Gsh1/Gsx1 and Gsh2/Gsx2. Migrating and invasive NSCs had elevated expression of mRNA encoding Pax6, Tenascin C (TNC), PDPN, Hey1, SPARC, p75NGFR and Gli3. On the basis of the strongest upregulation in invasion-induced NSCs, we defined a group of five key invasion-related genes: Ngfr, Sparc, Snail1, Pdpn and Tnc. These genes were co-expressed and upregulated in seven samples of glioblastoma multiforme (GBM) compared with normal human brain controls. Induction of invasion and migration led to low expression of differentiation markers and repressed proliferation in NSCs. Our results indicate that normal forebrain stem cells have the inherent ability to adopt a glioma-like invasiveness. The results provide a novel in vitro system to study stem cell invasion and a novel glioma invasion model: tumoral abuse of the developmental dorsoventral identity regulation.

Entities:  

Keywords:  BMP4; FGF2; Invasion; Migration; Neural stem cell

Mesh:

Substances:

Year:  2013        PMID: 23788430      PMCID: PMC3744023          DOI: 10.1242/jcs.125757

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  57 in total

Review 1.  The control of neural stem cells by morphogenic signals.

Authors:  David M Panchision; Ronald D G McKay
Journal:  Curr Opin Genet Dev       Date:  2002-08       Impact factor: 5.578

2.  Single factors direct the differentiation of stem cells from the fetal and adult central nervous system.

Authors:  K K Johe; T G Hazel; T Muller; M M Dugich-Djordjevic; R D McKay
Journal:  Genes Dev       Date:  1996-12-15       Impact factor: 11.361

3.  bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells.

Authors:  A L Vescovi; B A Reynolds; D D Fraser; S Weiss
Journal:  Neuron       Date:  1993-11       Impact factor: 17.173

4.  A self-renewing multipotential stem cell in embryonic rat cerebral cortex.

Authors:  A A Davis; S Temple
Journal:  Nature       Date:  1994-11-17       Impact factor: 49.962

Review 5.  Molecular genetics of neuronal migration disorders.

Authors:  Judy S Liu
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

Review 6.  Fibroblast growth factors in the developing central nervous system.

Authors:  M Ford-Perriss; H Abud; M Murphy
Journal:  Clin Exp Pharmacol Physiol       Date:  2001-07       Impact factor: 2.557

7.  Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.

Authors:  Kazuhiko Mishima; Yukinari Kato; Mika Kato Kaneko; Ryo Nishikawa; Takanori Hirose; Masao Matsutani
Journal:  Acta Neuropathol       Date:  2006-04-05       Impact factor: 17.088

Review 8.  The genetics of early telencephalon patterning: some assembly required.

Authors:  Jean M Hébert; Gord Fishell
Journal:  Nat Rev Neurosci       Date:  2008-09       Impact factor: 34.870

Review 9.  Cancer stem cells and glioma.

Authors:  Sunit Das; Maya Srikanth; John A Kessler
Journal:  Nat Clin Pract Neurol       Date:  2008-07-15

10.  Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours.

Authors:  N Yamada; M Kato; P ten Dijke; H Yamashita; T K Sampath; C H Heldin; K Miyazono; K Funa
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

View more
  14 in total

1.  Fibrogenic Lung Injury Induces Non-Cell-Autonomous Fibroblast Invasion.

Authors:  Neil Ahluwalia; Paula E Grasberger; Brian M Mugo; Carol Feghali-Bostwick; Annie Pardo; Moisés Selman; David Lagares; Andrew M Tager
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

2.  An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery.

Authors:  Martin H M Sailer; Durga Sarvepalli; Catherine Brégère; Urs Fisch; Marin Guentchev; Michael Weller; Raphael Guzman; Bernhard Bettler; Arkasubhra Ghosh; Gregor Hutter
Journal:  J Vis Exp       Date:  2016-08-23       Impact factor: 1.355

3.  KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.

Authors:  Kyung-Hwa Lee; Eun-Jung Ahn; Se-Jeong Oh; Ok Kim; Young-Eun Joo; Jeong-A Bae; Somy Yoon; Hyang-Hwa Ryu; Shin Jung; Kyung-Keun Kim; Jae-Hyuk Lee; Kyung-Sub Moon
Journal:  Oncotarget       Date:  2015-02-20

4.  Hairy/enhancer-of-split related with YRPW motif protein 1 promotes osteosarcoma metastasis via matrix metallopeptidase 9 expression.

Authors:  A Tsuru; T Setoguchi; Y Matsunoshita; H Nagao-Kitamoto; S Nagano; M Yokouchi; S Maeda; Y Ishidou; T Yamamoto; S Komiya
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

5.  Potential Effect of CD271 on Human Mesenchymal Stromal Cell Proliferation and Differentiation.

Authors:  Giovanna Calabrese; Raffaella Giuffrida; Debora Lo Furno; Nunziatina Laura Parrinello; Stefano Forte; Rosario Gulino; Cristina Colarossi; Luciana Rita Schinocca; Rosario Giuffrida; Venera Cardile; Lorenzo Memeo
Journal:  Int J Mol Sci       Date:  2015-07-09       Impact factor: 5.923

6.  Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.

Authors:  Jhon A Ochoa-Alvarez; Harini Krishnan; John G Pastorino; Evan Nevel; David Kephart; Joseph J Lee; Edward P Retzbach; Yongquan Shen; Mahnaz Fatahzadeh; Soly Baredes; Evelyne Kalyoussef; Masaru Honma; Martin E Adelson; Mika K Kaneko; Yukinari Kato; Mary Ann Young; Lisa Deluca-Rapone; Alan J Shienbaum; Kingsley Yin; Lasse D Jensen; Gary S Goldberg
Journal:  Oncotarget       Date:  2015-04-20

7.  CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma.

Authors:  Oihana Murillo-Sauca; Man Ki Chung; June Ho Shin; Christina Karamboulas; Shirley Kwok; Young Ho Jung; Richard Oakley; James R Tysome; Lovisa O Farnebo; Michael J Kaplan; Davud Sirjani; Vasu Divi; F Christopher Holsinger; Chafeek Tomeh; Anthony Nichols; Quynh T Le; A Dimitrios Colevas; Christina S Kong; Ravindra Uppaluri; James S Lewis; Laurie E Ailles; John B Sunwoo
Journal:  Oncotarget       Date:  2014-08-30

8.  RND3 promotes Snail 1 protein degradation and inhibits glioblastoma cell migration and invasion.

Authors:  Baohui Liu; Huimin Dong; Xi Lin; Xiangsheng Yang; Xiaojing Yue; Jian Yang; Yuntao Li; Liquan Wu; Xiaonan Zhu; Shenqi Zhang; Daofeng Tian; Junmin Wang; Qiang Cai; Shanping Mao; Qianxue Chen; Jiang Chang
Journal:  Oncotarget       Date:  2016-12-13

9.  Conservation of Epithelial-to-Mesenchymal Transition Process in Neural Crest Cells and Metastatic Cancer.

Authors:  April Zhang; Hira Aslam; Neha Sharma; Aryeh Warmflash; Walid D Fakhouri
Journal:  Cells Tissues Organs       Date:  2021-07-02       Impact factor: 2.208

10.  Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.

Authors:  Cristiano Farace; Jaime Antonio Oliver; Consolacion Melguizo; Pablo Alvarez; Pasquale Bandiera; Ana Rosa Rama; Giulia Malaguarnera; Raul Ortiz; Roberto Madeddu; Jose Prados
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.